longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

RTX

RTX

193.5401.67% ( -3.290 )
Closed: Sep 17, 15:59:58 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfileWeekly ReviewWeekly Review
LongbridgeAI
2026-W37 · 2026-09-07

RTX.US Weekly Report · 2026-W37

Executive Overview

RTX fell 1.55% last week, closing at $197.68. The stock rallied to $201.75 mid-week but retreated, swinging 2.72%. The latest earnings show EPS growth of ~30%, indicating solid profitability; institutional money is flowing in while retail investors are exiting, creating a stark divergence. Brokers are unanimously bullish with 19% upside to targets, yet the stock remains under pressure—possibly signaling market concern about earnings sustainability beyond this cycle.

Price Action

The week closed at $197.68, down 1.55% from Friday, September 4 close of $200.79. Trading ranged from $201.75 (September 8) to $196.31 (September 11), a 2.72% intraday swing. Four trading days (Sept 8–11) logged 13.28 million shares total, averaging 3.32 million per day—consistent with the 60-day median, showing neither unusual accumulation nor depletion. Turnover rate of 0.29% reflects stable liquidity.

The pattern shows strength early (Monday’s push to $201.75) followed by four consecutive down closes: $198.81 → $197.55 → $198.12 → $197.68. Attempted rallies failed to sustain, suggesting weakening upside momentum and potential profit-taking pressure.

Valuation & Earnings

Current P/E of 34.4x sits in the bottom quartile of the past 3 years—cheaper than 77.93% of historical readings over that period, placing valuation at fair to undervalued levels. P/B of 4.01x, with market cap of $266.4 billion.

Latest quarter (Q2 2026) results:

  • EPS $1.57, up 28.69% YoY
  • Revenue $24.71 billion, up 14.49% YoY
  • Net income $2.139 billion, up 29.09% YoY
  • Operating income $3.137 billion, up 25.88% YoY

Against consensus estimates: full-year EPS mean $7.375, median $7.413. Year-to-date (Q1+Q2) EPS of $3.08 implies a sub-$6.2 run-rate if paced equally, suggesting deceleration in H2.

Q2 net margin of 8.66% compressed from Q1’s 9.33%, hinting at mounting cost or competitive pressures.

Capital Flow

As of Tuesday afternoon (September 11, 8:00 PM), large-cap institutional money shows net inflow of 463.51 units, while retail sees net outflow of 137.66 units (inflow 2,099.30 vs. outflow 2,236.96). This is classic “smart money accumulating, retail capitulating” divergence, reflecting institutional confidence against retail flight-to-safety.

Broker Consensus

Among 23 analysts: 11 buy, 8 hold, 4 reduce, 0 sell. Nearly all rating mass is at the bullish end, with consensus “buy” recommendation.

Mean target price of $234.82 implies 18.79% upside from current levels. However, broker ratings lag price action and fresher information—they typically reflect backward-looking earnings and medium-term guides, not the market’s current repricing of near-term sustainability risks.

News & Catalysts

Two principal threads: (1) RTX announced partnership and investment in Xcimer Energy to develop advanced directed energy systems, advancing RTX’s footprint in next-gen defense tech. (2) Industry macro: AI-driven defense expansion—RTX and peers report record backlogs, with manufacturing capacity build as the competitive battleground.

Key news this week (by relevance):

  1. RTX Partners With and Invests in Xcimer Energy to Develop Advanced Directed Energy Technology
  2. AI Tailwinds and Record Backlogs Drive Top-Line Beats Across Sectors
  3. The Reboot of Industrial and Aerospace: Who Is Building and Who Is Sleeping?
  4. A New Era of American Power: AI, Mergers, and the Industrial Resurgence
  5. Weekly Recap | RTX -5.16%, most brokers rate it buy
  6. RTX’s Pratt & Whitney invests $25 million to expand precision parts manufacturing in Niepołomice, Poland
  7. RTX Raytheon completes USD 50 million expansion of Mississippi manufacturing facility
  8. Inside the Aerospace Boom: Next-Gen Weapons, AI Shifts, and a Historic Airline Expansion
  9. Uncharted Equities: RTX’s Mega Contract and the Self-Driving Shakeout
  10. US Defense Contractors Secure Massive AI and Submarine Deals Amid Naval Tech Overhaul

Signal Alignment & Tensions

RTX presents a “trilemma”:

  1. Valuation & Consensus Aligned — P/E at historical low-quartile, unanimous broker bullishness, 19% target premium all point to a safety margin and institutional conviction.

  2. Fundamentals Solid — Q2 EPS flat QoQ, up 29% YoY; revenue +15% YoY. Earnings acceleration intact, not yet decelerating.

  3. Capital Flow vs. Price Action Creates Friction — Institutional inflow pairs with retail outflow (textbook “dumb money out, smart money in”), yet the stock still fell 1.55%. This tension reveals:

    • Broker ratings and capital deployment are constructive, but insufficient to overcome market unease about earnings sustainability
    • EPS growth decelerated from Q1 (+32%) to Q2 (+29%): still robust, but directional slowdown may trigger profit-taking and multiple compression
    • Monday’s intraday rejection of $201.75 and the week’s four-bar lower-close pattern suggest real selling pressure—either profit-realization or risk-off positioning

Conclusion: Valuation, consensus, and capital momentum have not yet aligned into a unified conviction. Low multiples attracted institutional bottom-fishing, but markets are actively repricing earnings sustainability and the multiple-expansion runway. The next quarter’s guidance and realization will determine whether this weakness is opportunistic or predictive of deeper deceleration ahead.

This content is generated using Longbridge Skill and CLI with open data from the Developers platform. For reference only and does not constitute investment advice. Investments carry risks; please make decisions with caution.